Exactly and the forecast for the nuclear graphite market is to increase considerably in the next 5 to 10 years. So at the moment this is a 1.5 billion industry and potentially a 4 billion in a decade. As supply for nuclear graphite becomes more scarce later in the year prices also predicted to go as high as 40,000 per ton Sarytogan having access to cheap electricity will most likely be able to produce a superior product at a lower cost than its competitors. The main reason nuclear graphite is so expensive is because of the high costs associated with heating petroleum coke over extended periods of time. All Sarytogan needs to do is undercut its competitors and it can potentially capture a significant proportion of the market. All the naysayers coming out of the woodwork is actually an extremely positive sign. 7 million easily on track to be raised by options in November. Smart money is all over this getting set for the re-rate that is incoming with an extremely positive PFS.
- Forums
- ASX - By Stock
- Ann: Five Nines Graphite Purity Exceeded
Exactly and the forecast for the nuclear graphite market is to...
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGA (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.7¢ |
Change
-0.002(2.25%) |
Mkt cap ! $13.17M |
Open | High | Low | Value | Volume |
8.8¢ | 8.8¢ | 8.7¢ | $5.273K | 60.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3293 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3293 | 0.087 |
2 | 122000 | 0.085 |
1 | 43500 | 0.080 |
1 | 17371 | 0.079 |
1 | 25000 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 50000 | 1 |
0.096 | 21932 | 2 |
0.097 | 1917 | 1 |
0.100 | 174402 | 1 |
0.110 | 263787 | 6 |
Last trade - 14.51pm 13/11/2024 (20 minute delay) ? |
Featured News
SGA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online